Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab

PURPOSE: The benefit of radiation therapy (RT) becomes uncertain in the treatment of early stage diffuse large B-cell lymphoma (DLBCL) in the era of rituximab, positron emission topography (PET), and computed tomography (CT). We sought to retrospectively review modern patients with early stage I-II...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Christopher, Ricco, Anthony, Singh, Raj, Mukhopadhyay, Nitai, Skoro, Nevena, Girma, Selamawit, Deng, Xiaoyan, Song, Shiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260098/
https://www.ncbi.nlm.nih.gov/pubmed/35814857
http://dx.doi.org/10.1016/j.adro.2022.100930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260098/
https://www.ncbi.nlm.nih.gov/pubmed/35814857
http://dx.doi.org/10.1016/j.adro.2022.100930

Ejemplares similares